(Q33591929)

English

Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase (English)

1 reference

Europe PubMed Central

28 July 2017

peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

Gibbs TC

1

1 reference

Europe PubMed Central

28 July 2017

Payan J

2

1 reference

Europe PubMed Central

28 July 2017

Brett EM

3

1 reference

Europe PubMed Central

28 July 2017

Lindstedt S

4

1 reference

Europe PubMed Central

28 July 2017

Holme E

5

1 reference

Europe PubMed Central

28 July 2017

Clayton PT

6

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

1 October 1993

1 reference

Europe PubMed Central

28 July 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

28 July 2017

56

1 reference

Europe PubMed Central

28 July 2017

10

1 reference

Europe PubMed Central

28 July 2017

1129-1132

1 reference

Europe PubMed Central

28 July 2017

Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1015246

21 June 2018

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1015246

21 June 2018

Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1015246

21 June 2018

Hematin therapy for the neurologic crisis of tyrosinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8410015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neonatal screen for hereditary tyrosinaemia type I

1 reference

https://pubmed.ncbi.nlm.nih.gov/8410015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8410015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.56.10.1129

1 reference

Europe PubMed Central

28 July 2017

release_mceqh4ahmnbwhgus2d67cxfsre

1 reference

https://api.fatcat.wiki/v0/release/mceqh4ahmnbwhgus2d67cxfsre

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33591929&oldid=1982930443"